The Pederzoli Hospital, the only center in Veneto to perform septal alcoholization, continues to be at the forefront of cardiology. This innovative procedure allows for the treatment of obstructive hypertrophic cardiomyopathy without the need for surgery and can prevent the implantation of automatic defibrillators or extensive drug therapy.
Hypertrophic cardiomyopathy is a congenital disease that causes thickening of the septum, the muscle that divides the right and left cavities of the heart, disrupting blood flow. It is often undiagnosed due to the absence of symptoms and allows for a normal life. However, it can manifest with arrhythmias or symptoms of blood outflow obstruction from the left ventricle, such as dizziness, fainting, heart failure, or myocardial ischemia.
The minimally invasive procedure of septal alcoholization involves injecting medical alcohol into a coronary branch that supplies the portion of the septum responsible for the obstruction. This causes a small controlled infarction that thins the interventricular septum and improves blood outflow from the ventricle. Patients can return to their normal lives within a few days.
The Pederzoli Hospital in Peschiera del Garda is one of the few centers in Italy to offer this highly specialized procedure. The interventional cardiology team, led by Professor Imad Sheiban, recently successfully performed septal alcoholization on a symptomatic patient. The cardiology department of the hospital, headed by Dr. Filippo Leonardo, continues to be at the forefront of cardiology in the Verona, Veneto, and Italian regions.
Italian Version
